Related Experiment Video
Updated: Apr 29, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs in colorectal neoplasia: from pathobiology to clinical applications
Antonios N Gargalionis, Efthimia K Basdra, Athanasios G Papavassiliou1
1Department of Biological Chemistry, University of Athens Medical School, 75, M. Asias Street, 11527 Athens, Greece. papavas@med.uoa.gr.
Abstract:
MicroRNAs (miRNAs) are small, non-coding RNAs that can post-transcriptionally regulate gene expression via messenger RNA (mRNA) targeting. During the past few years several miRNA groups emerged as critical components of developmental and pathological processes, among them being cancer. In colorectal cancer (CRC) specifically, numerous miRNA molecules have been identified up- or downregulated functioning as tumor-specific markers with oncogenic and tumor-suppressive properties. Their dysregulation impacts impaired cellular processes such as cell proliferation, apoptosis, angiogenesis, invasion and metastasis. The detection of extracellular miRNAs in plasma and fecal samples of CRC patients tends to provide novel, non-invasive biomarkers in favor of CRC diagnosis and, at the same time, data from in vivo and in vitro CRC models reveal promising therapeutic applications through miRNA inhibition and miRNA delivery.
Insights
MicroRNAs (miRNAs) are key regulators in colorectal cancer (CRC) development and progression. Detecting extracellular miRNAs in patient samples offers promising non-invasive biomarkers for CRC diagnosis and potential therapeutic strategies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression post-transcriptionally.
- miRNAs play critical roles in both normal development and pathological conditions, including cancer.
- In colorectal cancer (CRC), dysregulated miRNAs act as oncogenes or tumor suppressors, affecting key cellular processes.
Purpose of the Study:
- To review the role of microRNAs in colorectal cancer.
- To highlight the potential of extracellular miRNAs as non-invasive biomarkers for CRC diagnosis.
- To discuss the therapeutic applications of miRNA-based strategies in CRC.
Main Methods:
- Literature review of studies on miRNA function in CRC.
- Analysis of data on extracellular miRNA detection in CRC patient samples (plasma, feces).
- Evaluation of in vivo and in vitro CRC models for miRNA-based therapeutics.
Main Results:
- Numerous miRNAs are identified as up- or downregulated in CRC, serving as tumor-specific markers.
- miRNA dysregulation impacts crucial cellular functions like proliferation, apoptosis, angiogenesis, invasion, and metastasis.
- Extracellular miRNAs in plasma and feces show potential as non-invasive diagnostic biomarkers for CRC.
Conclusions:
- MicroRNAs are integral to colorectal cancer pathogenesis.
- Extracellular miRNAs represent a promising avenue for non-invasive CRC diagnosis.
- miRNA inhibition and delivery strategies hold therapeutic potential for colorectal cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs

